Sutro Biopharma
IPO News: Filed S-1/A: Sutro Biopharma Launches 5mm Share IPO with $14.00 - $16.00 Marketing Range

Sutro Biopharma


Initial Filing Date: 08/29/18

Launch Date: 09/17/18  

Price Range: $14.00 - $16.00

Initial Shares Offered (mm): 5.0

Shares Offered (Pre-Shoe | mm): 5.0

Primary Shares (mm): 5.0

Secondary Shares (mm): 0.0

Amount Offered (@ Midpoint)(mm): $75.0

% Secondary: 0.0%

Shares Outstanding (mm): 22.2

Market Value at Midpoint (mm):  $332.3

Offering as % of Market Value:    22.6%

Bookrunners:  COWEN | PFJ

Co-Managers:  JMP Securities | Wedbush PacGrow 

Major Holders:  Alta Partners | Celgene Corp | Citadel Master Fund | Lilly Ventures | Merck Sharp & Dohme Corp | Samsara BioCapital | Skyline Ventures | SV Health Investors | Vida Ventures

Industry:  Healthcare

Description:  Sutro Biopharma is a clinical stage drug discovery, development and manufacturing company focused on leveraging their proprietary integrated cell-free protein synthesis platform, XpressCF, to create a broad variety of optimally designed, next-generation protein therapeutics for cancer and autoimmune disorders

Note:  Emerging Growth Company

Launch link: S-1/A